Supernus Pharmaceuticals SUPN Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's change in inventories?
- Supernus Pharmaceuticals (SUPN) reported change in inventories of $105K in Q1 2026.
- How has Supernus Pharmaceuticals's change in inventories changed year-over-year?
- Supernus Pharmaceuticals's change in inventories increased by 102.2% year-over-year, from -$4.73M to $105K.
- What is the long-term trend for Supernus Pharmaceuticals's change in inventories?
- Over 4 years (2021 to 2025), Supernus Pharmaceuticals's change in inventories has grown at a -15.3% compound annual growth rate (CAGR), from $14.58M to $7.5M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.